 The primary outcome of interest will be the effect of theophylline on exercise duration during constant load 75 maximum exercise testing. The study will be powered to detect a 20 greater improvement in exercise duration for the theophylline-treated group. Secondary outcome measures will include changes in spirometry FEV1 and lung volumes. 